We demonstrated that the TP53 GOF and KRAS variants in patients with left-sided CRC, and the TP53 non-GOF variant, BRAF V600E, and MYC amplification in patients with right-sided CC, were independent predictors of a shorter OS. The gene discussed is BRAF; the disease is colorectal carcinoma.